Delivery Order SPE2DB20D3103-SPE2DB25FP7H9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30-count units, valued at $1,134.20. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units under a firm fixed price contract on July 31, 2025. The contract, valued at $5,344.16, is scheduled for completion by August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award, demonstrating AmerisourceBergen's continued capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- The Defense Logistics Agency awarded a $2,761.61 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed and delivered from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $9,894.62. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a continuation of the company's pharmaceutical supply support to the federal government. The contract carries no set-aside designation and was competitively awarded through open procurement. Performance will be executed...
- The Defense Logistics Agency awarded a $2,438.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued to the pharmaceutical distributor's Corporate Office in Conshohocken, Pennsylvania. The delivery order represents a routine medical procurement fulfilling the federal government's pharmaceutical supply needs for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, with a ceiling value of $9,367.14. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $8,447.59. This firm fixed-price delivery order is scheduled for completion by August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a contract ceiling value of $1,304.62. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and carries an ultimate completion date of July 28, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed price contract valued at $1,669.23. The delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a small-value pharmaceutical procurement. This non-set-aside award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7H9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for Lidocaine 5% Patch in a quantity of 30 units, valued at $9,852.90. This competitively awarded, non-set-aside delivery order represents a firm fixed-price pharmaceutical supply transaction supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor under this comprehensive global contract vehicle, supplying a broad range of brand-name and generic medications, vaccines, medical supplies, and specialty pharmaceuticals to support military healthcare programs worldwide. The company's extensive portfolio demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 8/5/25 |